HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M800013-JLR200v1 M800013-JLR200v2 49/5/1056    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Manmontri, B. Articles by Brindley, D. N. Search for Related Content PubMed PubMed Citation Articles by Manmontri, B. Articles by Brindley, D. N. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 49, 1056-1067, May 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically^*

Boripont Manmontri^1,*, Meltem Sariahmetoglu^1,*, Jimmy Donkor, Maroun Bou Khalil, Meenakshi Sundaram, Zemin Yao, Karen Reue, Richard Lehner^** and David N. Brindley^2,*

^* Signal Transduction Research Group, Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2S2, Canada
^** Canadian Institute of Health Research Group on the Molecular and Cell Biology of Lipids, Department of Pediatrics, University of Alberta, Edmonton, Alberta T6G 2S2, Canada
Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
Departments of Human Genetics and Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095

^* This work was supported by awards from the Canadian Institute of Health Research (Grant MOP 81137), the Diabetes Association (Brooks and District), and the Alberta Heart and Stroke Foundation to D.N.B., by Canadian Institute of Health Research Grant MT-15486 to Z.Y., and by U. S. National Institutes of Health Grant HL-28481 to K.R. D.N.B. is the recipient of a Medical Scientist Award from the Alberta Heritage Foundation for Medical Research.

Published, JLR Papers in Press, February 15, 2008.

¹ B. Manmontri and M. Sariahmetoglu contributed equally to this work.

² To whom correspondence should be addressed. e-mail: david.brindley{at}ualberta.ca

Glucocorticoids (GCs) increase hepatic phosphatidate phosphatase (PAP1) activity. This is important in enhancing the liver's capacity for storing fatty acids as triacylglycerols (TAGs) that can be used subsequently for β-oxidation or VLDL secretion. PAP1 catalyzes the conversion of phosphatidate to diacylglycerol, a key substrate for TAG and phospholipid biosynthesis. PAP1 enzymes in liver include lipin-1A and -1B (alternatively spliced isoforms) and two distinct gene products, lipin-2 and lipin-3. We determined the mechanisms by which the composite PAP1 activity is regulated using rat and mouse hepatocytes. Levels of lipin-1A and -1B mRNA were increased by dexamethasone (dex; a synthetic GC), and this resulted in increased lipin-1 synthesis, protein levels, and PAP1 activity. The stimulatory effect of dex on lipin-1 expression was enhanced by glucagon or cAMP and antagonized by insulin. Lipin-2 and lipin-3 mRNA were not increased by dex/cAMP, indicating that increased PAP1 activity is attributable specifically to enhanced lipin-1 expression. This work provides the first evidence for the differential regulation of lipin activities. Selective lipin-1 expression explains the GC and cAMP effects on increased hepatic PAP1 activity, which occurs in hepatic steatosis during starvation, diabetes, stress, and ethanol consumption.

Supplementary key words β-oxidation • diabetes • ethanol ingestion • fasting • glucagon • hypertriglyceridemia • steatosis • triacylglycerol synthesis

Abbreviations: CPTcAMP, 8-(4-chlorophenylthio) cyclic AMP; DAG, diacylglycerol; dex, dexamethasone; ER, endoplasmic reticulum; GC, glucocorticoid; LPP, lipid phosphate phosphatase; PA, phosphatidate; PAP1, phosphatidate phosphatase; PGC-1, peroxisome proliferator-activated receptor-coactivator-1; TAG, triacylglycerol

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. B. Thrush, D. N. Brindley, A. Chabowski, G. J. Heigenhauser, and D. J. Dyck Skeletal Muscle Lipogenic Protein Expression Is Not Different between Lean and Obese Individuals: A Potential Factor in Ceramide Accumulation J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 5053 - 5061. [Abstract] [Full Text] [PDF]

				J. Donkor, P. Zhang, S. Wong, L. O'Loughlin, J. Dewald, B. P.C. Kok, D. N. Brindley, and K. Reue A Conserved Serine Residue Is Required for the Phosphatidate Phosphatase Activity but Not the Transcriptional Coactivator Functions of Lipin-1 and Lipin-2 J. Biol. Chem., October 23, 2009; 284(43): 29968 - 29978. [Abstract] [Full Text] [PDF]

				D. S. Douglas, J. L. Moran, J. R. Bermingham Jr, X.-J. Chen, D. N. Brindley, B. Soliven, D. R. Beier, and B. Popko Concurrent Lpin1 and Nrcam Mouse Mutations Result in Severe Peripheral Neuropathy with Transitory Hindlimb Paralysis J. Neurosci., September 30, 2009; 29(39): 12089 - 12100. [Abstract] [Full Text] [PDF]

				W. T. Festuccia, P.-G. Blanchard, V. Turcotte, M. Laplante, M. Sariahmetoglu, D. N. Brindley, and Y. Deshaies Depot-specific effects of the PPAR{gamma} agonist rosiglitazone on adipose tissue glucose uptake and metabolism J. Lipid Res., June 1, 2009; 50(6): 1185 - 1194. [Abstract] [Full Text] [PDF]

				K. Takeuchi and K. Reue Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1195 - E1209. [Abstract] [Full Text] [PDF]

				W. T. Festuccia, P.-G. Blanchard, V. Turcotte, M. Laplante, M. Sariahmetoglu, D. N. Brindley, D. Richard, and Y. Deshaies The PPAR{gamma} agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1327 - R1335. [Abstract] [Full Text] [PDF]

				K. Reue and J. R. Dwyer Lipin proteins and metabolic homeostasis J. Lipid Res., April 1, 2009; 50(Supplement): S109 - S114. [Abstract] [Full Text] [PDF]

				M. C. Gropler, T. E. Harris, A. M. Hall, N. E. Wolins, R. W. Gross, X. Han, Z. Chen, and B. N. Finck Lipin 2 Is a Liver-enriched Phosphatidate Phosphohydrolase Enzyme That Is Dynamically Regulated by Fasting and Obesity in Mice J. Biol. Chem., March 13, 2009; 284(11): 6763 - 6772. [Abstract] [Full Text] [PDF]

				G. M. Carman and G.-S. Han Phosphatidic Acid Phosphatase, a Key Enzyme in the Regulation of Lipid Synthesis J. Biol. Chem., January 30, 2009; 284(5): 2593 - 2597. [Full Text] [PDF]

				M. B. Khalil, M. Sundaram, H.-Y. Zhang, P. H. Links, J. F. Raven, B. Manmontri, M. Sariahmetoglu, K. Tran, K. Reue, D. N. Brindley, et al. The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL J. Lipid Res., January 1, 2009; 50(1): 47 - 58. [Abstract] [Full Text] [PDF]

				K. Reue and D. N. Brindley Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism J. Lipid Res., December 1, 2008; 49(12): 2493 - 2503. [Abstract] [Full Text] [PDF]

				P. Zhang, L. O'Loughlin, D. N. Brindley, and K. Reue Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis J. Lipid Res., July 1, 2008; 49(7): 1519 - 1528. [Abstract] [Full Text] [PDF]